Walgreens Investors' $36M Deal In Opioid Suit Gets First OK

By Henrik Nilsson · April 17, 2024, 11:17 PM EDT

An Illinois federal judge on Wednesday granted his initial approval of a $36 million settlement to end a stockholder's derivative suit accusing Walgreens and its leadership of failing to limit retail...

To view the full article, register now.